Please Wait...
Please Wait...
Please Wait...
Please Wait...
Please Wait...
Please Wait...
Please Wait...
Please Wait...
Please Wait...
Please Wait...
Please Wait...
Please Wait...
LTP
2.56 (1.94%)
Volume
7,50,345 Cr
Market Cap
₹1,730 Cr
52W Low - High
₹77.90 - ₹169.00
Sector
Realty
LTP
0.05 (0.00%)
Volume
747 Cr
Market Cap
₹2,179 Cr
52W Low - High
₹4,464.00 - ₹6,399.95
Sector
Chemicals
With ₹0 brokerage for first 30 days*
The Alembic Group, an Indian conglomerate headquartered in Vadodara, Gujarat, has a rich history dating back to its establishment in 1907 by Prof. T.K. Gajjar, Prof. A.S. Kotibhasker, and B.D. Amin. Originally known as Alembic Chemical Works Company Ltd, it began its journey with a focus on producing tinctures, alcohol, vitamins, and penicillin and later shifted to active pharmaceutical ingredients (API).
Over the years, Alembic Group has played a significant role in various industrial sectors. In response to supply chain disruptions from Europe during World War II, Alembic ventured into manufacturing glass bottles in 1943. This initiative led to the incorporation of Alembic Glass Industries Ltd. in 1944, later renamed Shreno Ltd. in 2005, to distinguish itself from the pharmaceutical business. The group’s diversification included the launch of YERA, India’s largest glassware brand, in 1958.
In 2010, Alembic Group underwent a demerger, separating its pharmaceutical business into a distinct entity known as Alembic Pharmaceuticals Ltd. The group’s flagship company now stands as the oldest pharmaceutical company in India.
The group’s scope extended beyond pharmaceuticals. In 2009, Alchemy Real Estate, the real estate arm of Alembic Group, emerged, focusing on developing residential townships, industrial plants, schools, commercial offices, and hospitals, primarily in Gujarat. Alchemy Real Estate launched its inaugural project in Bengaluru, Karnataka, in November 2014, expanding its horizons.
The Alembic Group is a diversified Indian conglomerate with activities spanning several industries:
Mr. Chirayu Amin, an M.B.A. graduate from the U.S.A., has been with the company since 1967 and currently serves as its Chairman. His leadership has steered the company to maintain consistent sales growth amid tough competition in the pharmaceutical industry. Mr. Amin has held various leadership roles in organisations such as FICCI-New Delhi, the International Chamber of Commerce (India Chapter), and the All India Organisation of Employers. He is also affiliated with the World Presidents’ Organization in the U.S.A. and is a Committee Member for the Federation of Gujarat Industries and FICCI.
Mrs. Malika Amin serves as the Managing Director and Chief Executive Officer of the company. Holding a Master of Arts degree, she joined the organisation in 1988 and boasts over 30 years of expertise in managing business strategy, administration, and human resources.
To invest in Group stocks via Angel One, follow these steps:
You can track the purchase status from the ‘Positions’ section in the ‘Orders’ module. Once the stock is delivered, you can track its gains and losses from your ‘Portfolio’.
Listed stocks of the Alembic Group include Alembic Pharmaceuticals Ltd and Alembic Ltd.
With a market cap of ₹18,484.80 crore, Alembic Pharmaceuticals Ltd has the largest market cap among the Alembic Group companies as of January 20, 2024.
The Alembic Group, founded in 1907 in Vadodara, Gujarat, India, traces its origins to the collaborative efforts of Prof. T.K. Gajjar, Prof. A.S. Kotibhasker, and B.D. Amin. Over the years, the group has evolved into one of the longstanding industrial entities in India, boasting a diversified range of business interests.
As of March 2023, Alembic Pharmaceuticals Ltd is the highest profit-making company under the Alembic Group, with a profit after tax of ₹ 7,927.03 crore.
As of January 20, 2024, Alembic Pharmaceuticals Ltd reported the highest debt of ₹722.02 crore under the Alembic Group.
₹0 brokerage for
first 30 days*